【Composition and Performance】

This product is composed of porous bioceramic artificial bone particles (≥30% pure β-TCP) and glycerol etc. as a shaping agent. The glycerol component is consistent with FDA-registered and marketed products of the same type. The porous bioceramic has a wellconnected porous structure with a total porosity of 70%±10% and an open porosity rate greater than 50%. Its well-connected porous structure provides conditions for new bone formation through osteoconduction. The product degrades within 6–24 months after implantation, releasing calcium and phosphate ions as components for bone regeneration during degradation. The glycerol shaping
agent is absorbable and it is beneficial for new bone formation.

【Indications for Use】

For filling and repairing bone defects in nonweight-bearing bones of limbs, spine, pelvis, and skull. Particularly suitable for minimally invasive and precise bone grafting.